...
首页> 外文期刊>European eating disorders review >Lisdexamfetamine Dimesylate Effects on Binge Eating Behaviour and Obsessive-Compulsive and Impulsive Features in Adults with Binge Eating Disorder
【24h】

Lisdexamfetamine Dimesylate Effects on Binge Eating Behaviour and Obsessive-Compulsive and Impulsive Features in Adults with Binge Eating Disorder

机译:Lisdexamfetamine Dimesylate对暴饮暴食成人的暴饮暴食行为及强迫和冲动特征的影响

获取原文
获取原文并翻译 | 示例
           

摘要

In a published 11-week, placebo-controlled trial, 50 and 70mg/d lisdexamfetamine dimesylate (LDX), but not 30mg/d LDX, significantly reduced binge eating days (primary endpoint) in adults with binge eating disorder (BED). This report provides descriptions of LDX effects on secondary endpoints (Binge Eating Scale [BES]; Three-Factor Eating Questionnaire [TFEQ]; Yale-Brown Obsessive Compulsive Scale modified for Binge Eating [Y-BOCS-BE]; and the Barratt Impulsiveness Scale, version 11 [BIS-11]) from that study. Week 11 least squares mean treatment differences favoured all LDX doses over placebo on the BES (p0.03), TFEQ Disinhibition and Hunger subscales (all p<0.05), and Y-BOCS-BE total, obsessive, and compulsive scales (all p0.02) and on BIS-11 total score at 70mg/d LDX (p=0.015) and the TFEQ Cognitive Restraint subscale at 30 and 70mg/d LDX (both p<0.05). These findings indicate that LDX decreased global binge eating severity and obsessive-compulsive and impulsive features of BED in addition to binge eating days. Copyright (c) 2015 John Wiley & Sons, Ltd and Eating Disorders Association.
机译:在一项已公布的为期11周的安慰剂对照试验中,使用50和70mg / d的赖氨苯丙胺二甲磺酸盐(LDX),而不是30mg / d LDX可以显着减少患有暴食症(BED)的成年人的暴食天数(主要终点)。该报告提供了LDX对次要终点的影响的描述(宾果饮食量表[BES];三因素饮食问卷[TFEQ];为暴饮暴食而修改的耶鲁-布朗强迫症量表[Y-BOCS-BE];以及巴拉特冲动量表,该研究的第11版[BIS-11])。第11周的最小二乘均值意味着在BES(p0.03),TFEQ抑制和饥饿子量表(p <0.05)和Y-BOCS-BE总,强迫和强迫量表(p0)上,所有LDX剂量均优于安慰剂。 .02)和BIS-11的总得分分别为70mg / d LDX(p = 0.015)和TFEQ认知约束子量表,分别为30和70mg / d LDX(p <0.05)。这些发现表明,LDX不仅减少了暴饮暴食天,还降低了全球暴饮暴食的严重程度以及BED的强迫症和冲动特征。版权所有(c)2015 John Wiley&Sons,Ltd和饮食失调协会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号